Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma

Area of Science:

• Lipid Metabolism
• Cardiovascular Disease Pathophysiology
• Biochemistry

Background:

• Primary hyperlipidemia involves abnormal plasma lipid levels.
• Cholesterol transport and esterification are critical for cellular and systemic lipid homeostasis.
• Dysregulation of these processes is implicated in atherosclerotic vascular disease.

Purpose of the Study:

• To investigate cholesterol metabolism abnormalities in primary hyperlipidemia.
• To correlate specific lipid transport and esterification patterns with different hyperlipidemia subtypes.
• To explore the relationship between altered sterol transport and cardiovascular disease risk.

Main Methods:

• Measured cholesterol esterification, cholesteryl ester transfer between lipoproteins, and sterol transport between cultured cells and plasma.
• Analyzed plasma from patients with hyperbetalipoproteinemia, dysbetalipoproteinemia, and hypertriglyceridemia, alongside normolipidemic controls.
• Correlated metabolic findings with clinical status, including cardiovascular disease presence.

Main Results:

• Hyperbetalipoproteinemia showed reduced cholesteryl ester transfer and reversed cell-plasma sterol transport.
• Dysbetalipoproteinemia exhibited increased esterification, reduced transfer, and reversed sterol transport.
• Hypertriglyceridemia with cardiovascular disease mirrored hyperbetalipoproteinemia patterns; those without disease had normal sterol transport.
• All hypertriglyceridemic patients with cardiovascular disease showed reversed cell-plasma sterol transport.

Conclusions:

• Significant, reproducible abnormalities in plasma cholesterol metabolism exist across distinct hyperlipidemia types.
• Altered sterol transport, particularly reversal of the normal direction, is a key finding in hyperlipidemic patients at risk for atherosclerotic vascular disease.
• Sterol metabolic measurements may hold predictive value for cardiovascular disease analysis.